CREATION OF A PROBIOTIC BIOLOGICAL PRODUCT BASED ON LACTOSE-UTILIZING MICROORGANISMS

Authors

  • M. K. Imanbayeva L.N. Gumilyov Eurasian National University, Nur-Sultan, Kazakhstan
  • R.A. Arynova Astana branch Limited Liability Partnership Kazakh research institute of processing and food industry, Nur-Sultan, Kazakhstan
  • Zh. K. Masalimov L.N. Gumilyov Eurasian National University, Nur-Sultan, Kazakhstan
  • A. Yu. Prosecov Kemerovo state university, Kemerovo, Russian Federation
  • G. Serikbay Astana branch Limited Liability Partnership Kazakh research institute of processing and food industry, Nur-Sultan, Kazakhstan

DOI:

https://doi.org/10.26577/eb.2021.v87.i2.08
        123 127

Abstract

Today 60% of the population of Kazakhstan suffers from hypolactasia. In addition, the production of lactose-free fermented milk products in the Kazakhstan market is observed in an insignificant amount. In this regard, the purpose of this scientific research is to develop a starter culture as a probiotic preparation based on lactic acid bacteria isolated from Kazakh traditional food products. The practical significance of the research lies in the ability to produce lactose-free fermented milk products in an industrial environment, based on the developed technology. Strains of Lactobacillus acidophilus, Enterococcus faecium were used as a starter culture. Our earlier studies have shown that lactobacilli have lactose-utilizing properties. Genetic identification of bacteria was carried out on the basis of the 16S rRNA gene; batch cultivation was used at different ranges of NaCl, pH. Experiments on the dynamics of growth were studied depending on the time of cultivation. Studies have shown that Lactobacillus acidophilus, Enterococcus faecium develop in an acidic pH˂7 environment. Selective breeding and development media are favorable, where the concentration of hydrochloric acid is about 5%. The applicability of the research results obtained is relevant for the microbiological, biotechnological and dairy industries. The practical significance of the results of this work lies in the import substitution of expensive probiotic preparations. The developed probiotic is cheaper than foreign counterparts at the price offer, since it is created on the basis of microorganisms isolated in the territory of the Republic of Kazakhstan.

References

Yang J., Fox M., Cong Y. Lactose intolerance in irritable bowel syndrome patients with diarrhoea: the roles of anxiety, activation of the innate mucosal immune system and visceral sensitivity // Aliment Pharmacol Ther. ‒ 2014. – Vol. 9. - P. 302‐311.

Wasuwanich P., Choudry H., Ingviya T., Scheimann O., Karla J., Yeung A., Karwowski C., Billet S., Buford N. A retrospective study on the association of gastrointestinal symptoms in children with low lactase activity and low activity of other disaccharidases. // BMC Gastroenterology. ‒ 2020. ‒ Vol. 12. ‒ R. 294 – 306.

Savaiano DA., Ritter AJ., Klaenhammer TR., James GM., Longcore AT., Chandler JR. Improving lactose digestion and symptoms of lactose intolerance with a novel galacto-oligosaccharide (RP-G28): a randomized, double-blind clinical trial // Nutr J. ‒ 2013. Vol. 11. ‒ P. 267 ‒ 278.

Mądry E., Krasińska B., Drzymała-Czyż S., Sands D., Lisowska A., Grebowiec P. Lactose malabsorption is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis patients. // Eur J Hum Genet. ‒ 2012. ‒ Vol. 10. R. 109–119.

Fedota O., Babalian V., Ryndenko V., Belyaev S., Belozorov I. Lactose tolerance and risk of multifactorial diseases on the example of gastrointestinal tract and bone tissuepathologies // Georgian medical newsIssue. ‒ 2020. ‒ Vol. 12. ‒ R. 243 – 255.

Lomer M., Parkes G., Sanderson J. Lactose intolerance in clinical practice–myths and realities // Aliment Pharmacol Ther. ‒ 2008. ‒ Vol. 15. ‒ P. 103 – 118.

Suchy FJ., Brannon PM., Carpenter TO. National institutes of health consensus development conference: Lactose intolerance and health // Ann Intern Med. ‒ 2010. Vol. ‒ 8. ‒ P. 792‐800.

Ratajczak A., Rychter A., Zawada A., Dobrowolska A., Kaz´mierczak I. Lactose intolerance in patients with inflamma- tory bowel diseases and dietary management in prevention of osteoporosis // Nutrition. ‒ 2020. ‒ Vol. 12. ‒ R. ‒ 139- 151.

Fassio F., Facioni MS., Guagnini F. Lactose Maldigestion, Malabsorption, and Intolerance: A Comprehensive Review with a Focus on Current Management and Future Perspectives // Nutrients. ‒ 2018. ‒ Vol. 15. - R. 187 – 202.

Meidistria T R., Sembiring L., Rahayu E S., Haedar N, Dwyana Z. Survival of Lactobacillus plantarum dad 13 in probiotic cheese making // IOP Conf. Series: Earth and Environmental Science. ‒ 2020. ‒ Vol. 15. ‒ R. 120-135.

Escobar-Ramírez M.C., Ordaz J.J., Escorza-Iglesias V.A., Rodríguez-Serrano G.M., Contreras-López E., Ramírez-Godínez J., Castan˜eda-Ovando A., Morales-Estrada A.I, Felix-Reyes N., González-Olivares L.J. Lactobacillus pentosus ABHEAU-05: An in vitro digestion resistant lactic acid bacterium isolated from a traditional fermented Mexican beverage // Rev Argent Microbiol. ‒ 2020. ‒ Vol. 9. ‒R. 305 – 314.

Larissa P., Margalho N., Genesy P., Jorge Deise A. P., Noleto Christian E., Júlia S., Marcos F. Biopreservation and probiotic potential of a large set of lactic acid bacteria isolated from Brazilian artisanal cheeses: from screening to in product approach. // Microbiol Res. ‒ 2021. ‒ Vol. 15. ‒ P. 242 – 254.

Azcarate-Peril MA., Ritter AJ., Savaiano D. Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals // Proc Natl Acad Sci U S A. ‒ 2017. ‒ Vol. 15. ‒ R. 114 – 129.

Ulisa Pachekrepapol U., Somboonchai N., Krimjai W. Physicochemical, rheological, and microbiological properties of lactose-free functional yogurt supplemented with fructooligosaccharides // J Food Process Preserv. ‒ 2020. ‒ Vol. 15. ‒ R. 150 – 165.

Galat A., Dufresne J., Combrisson J., The´paut J., Boumghar-Bourtchai L., Boyer M., Fourmestraux M.Novel method based on chromogenic media for discrimination and selective enumeration of lactic acid bacteria in fermented milk products // Food Microbiol. ‒ 2016. ‒ Vol. 10. ‒ R. 163- 173.

Rizzoli R., Biver E. Effects of Fermented Milk Products on Bone // Calcif Tissue Int. ‒ 2018. ‒ Vol. 12. R. ‒ 102-114.

Borghini R., Donato G., Alvaro D., Picarelli A. New insights in IBS‐like disorders: Pandora's Box has been opened; review // Gastroenterol Hepatol Bed Bench. ‒ 2017. ‒ Vol. 10. R. ‒ 79‐89.

Scrimshaw NS., Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intol- erance // Am J Clin Nutr. ‒ 2015. ‒ Vol. 15. ‒ P. 107-122.

Egorova N.S. Rukovodstvo k prakticheskim zanyatiyam po mikrobiologii // MGU. ‒ 1995. – C. 186 - 198

Netrusova A.I. Praktikum po mikrobiologii // Akademiya. ‒ 2005. – C. 119 – 129.

Vegas E.Z.S., Nieves B., Araque M. et al. Outbreak of Infection With Acinetobacter Strain RUH 1139 in an Intensive Care Unit // Infection control and hospital epidemiology. – 2006. - Vol. 27. - P. 397 – 424.

Werle E., Schneider C., Renner M. et al. Convenient single-step, one tube purification of PCR products for direct sequencing // Nucleic Acids Res. – 1994. – Vol. 22. ‒ P. 4354-4376.

Egorova N.S. Mikrobiologiya // Vysshaya shkola. ‒ 1989. ‒ C. 321 – 376.

Evseev V. Laboratornyj praktikum mikroorganizmov // Kurgan. ‒ 2008.- C. 131 – 143.

GOST 26809-86 "Moloko i molochnye produkty. Pravila priemki, metody otbora i podgotovka prob k analizu" // Standartinform. ‒ 2010. C. 10 – 258.

Downloads

How to Cite

Imanbayeva М. К. ., Arynova Р. А. ., Masalimov Ж. К. ., Prosecov А., & Serikbay Г. (2021). CREATION OF A PROBIOTIC BIOLOGICAL PRODUCT BASED ON LACTOSE-UTILIZING MICROORGANISMS. Experimental Biology, 87(2), 80–90. https://doi.org/10.26577/eb.2021.v87.i2.08